Lenovo’s Supercomputer Revolutionizes Research at European Institute of Oncology and Monzino Cardiology Center
In a groundbreaking development, Lenovo has announced the provision of a High Performance Computing (HPC) system to the European Institute of Oncology (IEO) and the Monzino Cardiology Center, aimed at significantly enhancing research capabilities in the fields of oncology and cardiology. This powerful supercomputer will facilitate the creation of advanced computational models that are essential for predicting, diagnosing, and understanding the interactions of protein structures within the human body. By leveraging machine learning and artificial intelligence (AI), this initiative promises to accelerate scientific research and improve patient outcomes through more personalized and effective therapeutic solutions.
The deployment of Lenovo’s HPC system represents a pivotal step in the IEO Monzino Group’s ongoing commitment to harnessing data-driven strategies for research and healthcare delivery. The supercomputer’s capabilities are expected to transform the way bioinformaticians and researchers approach complex medical challenges, by enabling them to process vast amounts of clinical data and molecular simulations with unprecedented speed and accuracy.
Transforming Research with Artificial Intelligence
Artificial intelligence plays a crucial role in modern healthcare by enabling the processing of large datasets, which are instrumental in developing new therapeutic solutions and preventive tools. The integration of AI into research practices allows for the swift identification of potential molecular candidates and their interaction mechanisms, thereby streamlining the process of drug discovery and clinical trial development. This technological advancement provides researchers with the ability to design increasingly customized treatment plans, tailored to the unique needs of individual patients.
The IEO Monzino Group has been at the forefront of adopting AI-driven research methodologies. To this end, they have developed sophisticated software platforms that facilitate access to advanced bioinformatics tools requiring high computing power. The collaboration with Lenovo, a global leader in technology solutions, has resulted in the establishment of a robust HPC infrastructure that incorporates machine learning models to extract critical clinical, molecular, and multi-omics data.
A Multidisciplinary Approach to Data-Driven Research
Annarosa Farina, the Chief Information Manager and Chief Data Officer at IEO Group, emphasized the significance of Lenovo’s HPC system in advancing their research objectives. She noted, "For years, our group has embraced a data-driven strategy for research, patient care, and governance. The HPC infrastructure provided by Lenovo accelerates and streamlines our data processing capabilities, which is essential for implementing our strategic vision. Our multidisciplinary approach involves collaboration among researchers, doctors, bioinformaticians, and data scientists, each contributing their unique expertise to extract valuable insights from complex data."
The new HPC system, boasting 475 TFlops of computing power, consists of Lenovo ThinkSystem SR645 V3 and ThinkSystem SR685a V3 servers, augmented by NVIDIA H200 GPUs. These GPUs are notable for being the first to offer 141 gigabytes of HBM3e memory, capable of operating at 4.8 terabytes per second. Additionally, the infrastructure is supported by a Lenovo ThinkSystem DE6400F storage system, ensuring advanced data management and accessibility.
A Leap Forward in Personalized Medicine
Alessandro de Bartolo, General Manager of Lenovo’s Infrastructure Solutions Group in Italy, expressed pride in the company’s contribution to scientific research. "We are extremely proud to make our systems available to the IEO Monzino Group. Our solutions’ ability to handle vast data volumes and expedite analysis will significantly contribute to advances in personalized medicine. The application of AI in this domain exemplifies its potential to positively impact society by enhancing the precision of diagnoses and treatments, thereby increasing healthcare efficiency."
The project was executed in partnership with Lenovo HPCNow! and Lenovo Professional Services, which provided valuable technical and organizational expertise. By implementing open-source software solutions, they have effectively optimized the research center’s operational activities, ensuring seamless access to hardware and computational resources.
About the European Institute of Oncology
Founded in 1994, the European Institute of Oncology (IEO) is a leading Scientific Institute for Research, Hospitalization, and Healthcare (IRCCS) dedicated to oncology. Inspired by innovative international models, the IEO offers cutting-edge treatments while conducting rigorous research across all aspects of cancer care, from prevention and screening to treatment and follow-up. The institute is renowned for its patient-centric approach, ensuring that all activities are designed to address the comprehensive needs of patients, far beyond their immediate health concerns.
About the Monzino Cardiology Center
Established in Milan in 1981, the Monzino Cardiology Center is Europe’s first hospital dedicated exclusively to cardiovascular research, treatment, and prevention. As a Scientific Institute for Research, Hospitalization, and Healthcare, the center joined the IEO Group in 2000. It is committed to high specialization, interdisciplinary research, and continuous service, consistently prioritizing patient care and service quality.
In conclusion, Lenovo’s provision of a cutting-edge HPC system marks a significant milestone for the IEO Monzino Group, equipping them with the tools necessary to drive innovation in oncology and cardiology research. By enabling the rapid processing and analysis of complex datasets, this collaboration is set to propel scientific discovery and improve patient care through personalized medicine. The integration of AI and high-performance computing in healthcare not only enhances research capabilities but also holds the promise of revolutionizing medical practices on a global scale.
For more Information, Refer to this article.
